LONDON--(BUSINESS WIRE)--
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 19 February 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
2,064,059 |
1.60% |
485,387 |
0.38% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
153,127 |
0.12% |
266,730 |
0.21% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
| purchase/sell: | 6,000 |
0.00% |
6,000 |
0.00% |
|
|
|
|
|
||
(4) |
TOTAL: |
|
|
|
|
2,223,186 |
1.72% |
758,117 |
0.59% |
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities |
Price per unit |
| Purchase | 2 |
226.2300 USD |
| Purchase | 2 |
224.8650 USD |
| Purchase | 2 |
225.0350 USD |
| Purchase | 15 |
224.0100 USD |
| Purchase | 94 |
224.7400 USD |
| Purchase | 100 |
224.9850 USD |
| Purchase | 100 |
224.6100 USD |
| Purchase | 100 |
224.6700 USD |
| Purchase | 100 |
224.5400 USD |
| Purchase | 154 |
224.6051 USD |
| Purchase | 200 |
224.8000 USD |
| Purchase | 200 |
224.9975 USD |
| Purchase | 238 |
224.7747 USD |
| Purchase | 340 |
224.6886 USD |
| Purchase | 360 |
224.8877 USD |
| Purchase | 400 |
224.9115 USD |
| Purchase | 404 |
224.7245 USD |
| Purchase | 416 |
224.7454 USD |
| Purchase | 599 |
224.7942 USD |
| Purchase | 640 |
224.7871 USD |
| Purchase | 723 |
224.8543 USD |
| Purchase | 1,037 |
224.7724 USD |
| Purchase | 1,303 |
224.7539 USD |
| Purchase | 1,434 |
224.7900 USD |
| Purchase | 2,423 |
224.4700 USD |
| Purchase | 2,505 |
224.7789 USD |
| Purchase | 2,538 |
224.9191 USD |
| Purchase | 3,944 |
224.7656 USD |
| Purchase | 4,148 |
224.7229 USD |
| Purchase | 6,249 |
224.7615 USD |
| Purchase | 6,348 |
224.7287 USD |
| Purchase | 7,301 |
224.7296 USD |
| Purchase | 7,825 |
224.7750 USD |
| Purchase | 15,483 |
224.6831 USD |
| Purchase | 19,676 |
224.9800 USD |
| Sale | 2 |
225.0350 USD |
| Sale | 2 |
224.8650 USD |
| Sale | 2 |
224.8600 USD |
| Sale | 5 |
224.9400 USD |
| Sale | 33 |
224.5936 USD |
| Sale | 100 |
224.6180 USD |
| Sale | 100 |
224.5000 USD |
| Sale | 100 |
224.9850 USD |
| Sale | 200 |
224.9450 USD |
| Sale | 360 |
224.8877 USD |
| Sale | 382 |
224.7314 USD |
| Sale | 400 |
224.9115 USD |
| Sale | 540 |
224.5407 USD |
| Sale | 559 |
224.7246 USD |
| Sale | 788 |
224.7378 USD |
| Sale | 823 |
224.8246 USD |
| Sale | 900 |
224.7644 USD |
| Sale | 1,117 |
225.0664 USD |
| Sale | 1,347 |
224.7073 USD |
| Sale | 1,434 |
224.7900 USD |
| Sale | 2,142 |
224.7572 USD |
| Sale | 2,280 |
224.4700 USD |
| Sale | 3,562 |
224.7693 USD |
| Sale | 4,307 |
224.7775 USD |
| Sale | 8,313 |
224.7269 USD |
| Sale | 8,528 |
224.9802 USD |
| Sale | 11,069 |
224.9800 USD |
| Sale | 12,762 |
224.6841 USD |
| Sale | 25,000 |
224.7527 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 22 Feb 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
|
to which the option |
|
|
|
|
|
or derivative |
|
|
|
|
|
relates |
|
|
|
|
| Call Options | Purchased |
6,000 |
220.0000 |
American |
Jul 16, 2021 |
| Put Options | Purchased |
-6,000 |
200.0000 |
American |
Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.